Medical Condition News

RSS

Kent State University receives four-year, $2.7M grant to study cognitive status of heart failure patients

The National Institutes of Health has awarded a $2.7-million grant to Kent State University for a collaborative research project with Case Western Reserve University School of Nursing, Summa Health System in Akron and University Hospitals Case Medical Center in Cleveland to study cognitive impairment in heart failure patients.

7 May 2010

Spousal caregivers frequently show memory deficits: Study

Husbands or wives who care for spouses with dementia are six times more likely to develop the memory-impairing condition than those whose spouses don't have it, according to results of a 12-year study led by Johns Hopkins, Utah State University, and Duke University.

7 May 2010

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

A post-hoc analysis of a Phase 3 safety study demonstrated that NUCYNTA® (tapentadol) tablets were associated with a lower incidence of nausea, vomiting and constipation when compared to oxycodone immediate release (IR) tablets in elderly patients with moderate to severe low-back or osteoarthritis pain.

7 May 2010

Telemedical Retinal Image Analysis and Diagnosis technology permits early detection of diabetic retinopathy

Automated Medical Diagnostics, a startup company based in Memphis, envisions its product helping to preserve the sight of millions of people at risk of vision loss from diabetic retinopathy.

7 May 2010

First 3-year results of world's largest temporomandibular joint disorder study reported at APS meeting

Scientists with the University of Maryland Dental School and collaborators at three other major universities will report results from the first three years of the world's largest study yet of a mysterious yet common pain syndrome involving the jaw at 8:30 a.m.on May 7 at the annual scientific meeting of the American Pain Society (APS). This year it is being held at the Baltimore Convention Center.

7 May 2010

Cytori Therapeutics to initiate European medical device approval study for Celution System

The first clinical trial of adipose (fat) tissue-derived stem and regenerative cells for the treatment of heart attacks showed a substantial reduction in the size of injury to the heart, an improvement in the amount of blood supply to the heart muscle, and a corresponding functional improvement in the amount of blood the heart can pump.

7 May 2010

Nile Therapeutics completes dose escalation in CD-NP Phase II study for acute decompensated heart failure

Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced that it has completed the dose escalation stage of an ongoing Phase II study of CD-NP in patients with acute decompensated heart failure. Nile had previously announced that the study, NIL-CDNP-CT005, was expanded to permit additional dose exploration prior to proceeding to larger Phase II studies.

7 May 2010

Fragile X syndrome iPS cells and embryonic stem cells behave differently: Study

In the last three years, a new technique for reprogramming adult cells has given scientists an easier and less controversial way to harness the power of embryonic-like stem cells to study human disease from its earliest beginnings in hopes of gleaning new insights into the root causes of disease and developing new therapies.

7 May 2010

Closer to understanding age-related memory loss and drug to boost memory

The world's scientific community may be one step closer to understanding age-related memory loss, and to developing a drug that might help boost memory. In an editorial published May 7 in Science, J. David Sweatt, Ph.D., chair of the University of Alabama at Birmingham (UAB) Department of Neurobiology, says that drugs known as histone deacetylase inhibitors are showing great promise in stopping memory loss - and even in boosting the formation of memory in animal models.

7 May 2010

MUHC's Henry C. Witelson Ocular Pathology Laboratory celebrates tenth anniversary

The Burnier International Ocular Pathology Society is holding a Scientific Colloquium in Montreal today to mark the tenth anniversary of the McGill University Health Centre's Henry C. Witelson Ocular Pathology Laboratory. The lab is an internationally reputed centre for the study and treatment of eye diseases and is leading a global network for the sharing of healthcare knowledge and expertise.

7 May 2010

Socioeconomic status, social context more important than race when analyzing obesity disparities: Study

When analyzing obesity disparities among women, socioeconomic status and social context may be more important than race, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health's Hopkins Center for Health Disparities Solutions.

7 May 2010

Over 22% of non-elderly Americans may be denied coverage due to pre-existing health conditions

Approximately 57.2 million people under the age of 65—more than one in five (22.4 percent) of America's non-elderly population—have a diagnosed pre-existing condition that could lead to a denial of coverage in the individual health insurance market, according to a report released today by the consumer health organization Families USA.

7 May 2010

M-3 Information introduces iPhone application for depression, anxiety disorders

M-3 Information entered the smart phone application environment by offering the M-3 Checklist, a scientifically validated screen for depression and anxiety disorders, at the iTunes store on Friday, April 30, 2010. Adapted from M-3 Information's existing mymoodmonitor.com website, this mobile version, called mym3, provides the same validated mental health questionnaire optimized for smart phones. A first in iPhone applications, mym3 is designed to create a bridge between user responses and recommendations set forth in the content-rich M3 website application.

7 May 2010

First clinical trial results of camera chip implanted under retina presented at 2010 ARVO meeting

Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of findings from their first clinical trial in which blind patients were able to view and focus on objects as their eye and head naturally moved as opposed to needing to constantly move their head to scan a scene, which is the case for other implants in which a camera is mounted to the patient's head.

7 May 2010

DUSA Pharmaceuticals receives notice of allowance for patent covering blue light technology

DUSA Pharmaceuticals, Inc.®, a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), today announced that the United States Patent and Trademark Office has issued a notice of allowance for a key patent related to its proprietary PDT light source, the BLU-U®, Blue Light Photodynamic Therapy Illuminator.

7 May 2010

Intellipharmaceutics generic Effexor XR ANDA accepted for filing by the FDA

Intellipharmaceutics International Inc., today announced that the Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for a generic version of the antidepressant Effexor XR® (venlafaxine hydrochloride).

7 May 2010

Researchers analyze relationship between extent of resection and outcome in patients with glioblastoma

Gliomas arise from the supporting cells of the brain, called the glia. These cells are subdivided into astrocytes, ependymal cells and oligodendroglial cells (or oligos). These tumors are graded from the lowest grade 1 to highest grade 4, with glioblastoma multiforme being the highest grade and deadliest type of glioma.

7 May 2010

New research examines coping and appraisal of disease-related pain

Growing evidence suggests how individuals cope with and appraise disease-related pain, such as arthritis or cancer, is related not only to their experience with pain but also to their physical and psychological functioning, according to new research presented here today in a plenary session talk at the American Pain Society's annual scientific meeting.

7 May 2010

Minimally invasive scopes to detect cancer

Just as cameras and televisions have been reinvented in the last decade with improved optics, sharpness and brightness, so have the tiny imaging scopes that physicians use to peer into the body's nooks and crannies -- its organs and digestive system.

7 May 2010

Kaposi's Sarcoma-associated herpesvirus replicates, spreads by hijacking PYM cellular protein

Research from the University of Leeds has identified how the virus which causes Kaposi's Sarcoma replicates and spreads - opening a door to a possible new treatment for the disease.

7 May 2010

Medical Condition News

Kent State University receives four-year, $2.7M grant to study cognitive status of heart failure patients

Spousal caregivers frequently show memory deficits: Study

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

Telemedical Retinal Image Analysis and Diagnosis technology permits early detection of diabetic retinopathy

First 3-year results of world's largest temporomandibular joint disorder study reported at APS meeting

Cytori Therapeutics to initiate European medical device approval study for Celution System

Nile Therapeutics completes dose escalation in CD-NP Phase II study for acute decompensated heart failure

Fragile X syndrome iPS cells and embryonic stem cells behave differently: Study

Closer to understanding age-related memory loss and drug to boost memory

MUHC's Henry C. Witelson Ocular Pathology Laboratory celebrates tenth anniversary

Socioeconomic status, social context more important than race when analyzing obesity disparities: Study

Over 22% of non-elderly Americans may be denied coverage due to pre-existing health conditions

M-3 Information introduces iPhone application for depression, anxiety disorders

First clinical trial results of camera chip implanted under retina presented at 2010 ARVO meeting

DUSA Pharmaceuticals receives notice of allowance for patent covering blue light technology

Intellipharmaceutics generic Effexor XR ANDA accepted for filing by the FDA

Researchers analyze relationship between extent of resection and outcome in patients with glioblastoma

New research examines coping and appraisal of disease-related pain

Minimally invasive scopes to detect cancer

Kaposi's Sarcoma-associated herpesvirus replicates, spreads by hijacking PYM cellular protein

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News